Clinical Trial Update: Cisplatin With or Without Raltitrexed in Treating Patients With Malignant Mesothelioma of the Pleura [Phase 3]

View source ↗

Summary

Phase 3 trial comparing cisplatin with or without raltitrexed in malignant mesothelioma of the pleura has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Mesothelioma

Drugs mentioned

• CISPLATIN (cisplatin)
• Tomudex (ZD1694)

Snippet

Sponsor: European Organisation for Research and Treatment of Cancer - EORTC | Conditions: Malignant Mesothelioma | Phase 3 | Status: COMPLETED